β3-adrenergic eNOS stimulation in left ventricular murine myocardium

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 10, 2006, Pages 1051-1060

  Brixius, Klara ^a,b   Bloch, Wilhelm ^b   Ziskoven, Christoph ^a   Bölck, Birgit ^a   Napp, Andreas ^a   Pott, Christian ^a   Steinritz, Dirk ^c   Jiminez, Maria ^d   Addicks, Klaus ^a   Giacobino, Jean Paul ^d   Schwinger, Robert H G ^a,e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e Klinikum Weiden   (Germany)

Author keywords

3 adrenoceptor; BRL 37344; eNOS; Myocardium

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCENT DYE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SERINE; 4,5 DIAMINOFLUORESCEIN; 4,5-DIAMINOFLUORESCEIN; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ETHANOLAMINE DERIVATIVE; FLUORESCEIN; FREE RADICAL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; ENZYME ACTIVITY; HEART LEFT VENTRICLE; HEART MUSCLE; HEART RIGHT ATRIUM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; CELL MEMBRANE; ENZYMOLOGY; GENETICS; HEART; HEART VENTRICLE; INNERVATION; MALE; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TISSUE FIXATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; CELL MEMBRANE; ETHANOLAMINES; FLUORESCEIN; FREE RADICALS; HEART; HEART VENTRICLES; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; SIGNAL TRANSDUCTION; TISSUE FIXATION;

EID: 33845732456     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-033     Document Type: Article

References (27)

1. Arch, J.R., and Wilson, S. 1996. β 3-adrenoceptors and the regulation of metabolism in adipose tissues. Biochem. Soc. Trans. 24: 412-418.
2. Bauer, P.M., Fulton, D., Boo, Y.C., Sorescu, G.P., Kemp, B.E., Jo, H., and Sessa, W.C. 2003. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J. Biol. Chem. 278: 14841-14849. doi:10.1074/jbc.M211926200.
3. Bloch, W., Mehlhorn, U., Krahwinkel, A., Reiner, M., Dittrich, M., Schmidt, A., and Addicks, K. 2001. Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide, 5: 317-333. doi:10.1006/niox.2000.0339.
4. Brixius, K., Bundkirchen, A., Bolck, B., Mehlhorn, U., and Schwinger, R.H.G. 2001. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium. Br. J. Pharmacol. 133: 1330-1338. doi:10.1038/sj.bjp.0704188.
5. Brixius, K., Bloch, W., Pott, C., Napp, A., Krahwinkel, A., Ziskoven, C., et al. 2004. Mechanisms of β 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. Br. J. Pharmacol. 143: 1014-1022. doi:10.1038/sj.bjp.0705983.
6. Chesley, A., Lundberg, M.S., Asai, T., Xiao, R.P., Ohtani, S., Lakatta, E.G., and Crow, M.T. 2000. The β(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ. Res. 87: 1172-1179.
7. De Lean, A., Hancock, A., and Lefkowitz, R.J. 1982. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 21: 5-16.
8. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., and Zeiher, A.M. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (London), 399: 601-605.
9. El Jamali, A., Freund, C., Rechner, C., Scheidereit, C., Dietz, R., and Bergmann, M.W. 2004. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta. FASEB J. 18: 1096-1098.
10. Feron, O., and Kelly, R.A. 2001. The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ. Res. 88: 129-131.
11. Fleming, I., and Busse, R. 2003. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. 284: R1-R12.
12. Fulton, D., Gratton, J.P., McCabe, T.J., Fontana, J., Fujio, Y., Walsh, K., et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (London), 399: 597-601.
13. Gauthier, C., Leblais, V., Kobzik, L., Trochu, J.-N., Khandoudi, N., Bril, A., Balligand, J.-L., and Le Marec, H. 1998. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest. 102: 1377-1384.
14. Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., and Le Marec, H. 1996. Functional β 3-adrenoceptor in the human heart. J. Clin. Invest. 98: 556-562.
15. Greif, D.M., Kou, R., and Michel, T. 2002. Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites. Biochemistry, 41: 15845-15853. doi:10.1021/bi026732g.
16. 3-adrenoceptor function in murine heart. Br. J. Pharmacol. 136: 217-229. doi:10.1038/sj.bjp.0704700.
17. Kojima, H., Nakatsubo, N., Kikuchi, K., Kawahara, S., Kirino, Y., Nagoshi, H., Hirata, Y., and Nagano, T. 1998. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70: 2446-2453. doi:10.1021/ac9801723.
18. Michel, J.B., Feron, O., Sase, K., Prabhakar, P., and Michel, T. 1997. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J. Biol. Chem. 272: 25907-25912. doi:10.1074/jbc.272.41.25907.
19. 3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation, 103: 1649-1655.
20. Petroff, M.G., Kim, S.H., Pepe, S., Dessy, C., Marban, E., Balligand, J.L., and Sollott, S.J. 2001. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat. Cell Biol. 3: 867-873. doi:10.1038/ncb1001-867.
21. 3-adrenoceptors in human atrial myocardium. Br. J. Pharmacol. 138: 521-529. doi:10.1038/sj.bjp.0705065.
22. Prabhakar, P., Thatte, H.S., Goetz, R.M., Cho, M.R., Golan, D.E., and Michel, T. 1998. Receptor-regulated translocation of endothelial nitric-oxide synthase. J. Biol. Chem. 273: 27383-27388. doi:10.1074/jbc.273.42.27383.
23. Revelli, J.-P., Preitner, F., Samec, S., Muniesa, P., Kuehne, F., Boss, O., et al. 1997. Targeted gene disruption reveals a leptin-independent role for the mouse β3-adrenoceptor in the regulation of body composition. J. Clin. Invest. 100: 1098-1106.
24. Schwinger, R.H.G., Böhm, M., Pieske, B., and Erdmann, E. 1991. Different β-adrenoceptor-effector coupling in human ventricular and atrial myocardium. Eur. J. Clin. Invest. 21: 443-451.
25. 2+-ATPaSe activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation, 92: 3220-3228.
26. Shen, Y.T., Cervoni, P., Claus, T., and Vatner, S.F. 1996. Differences in β3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J. Pharmacol. Exp. Ther. 278: 1435-1443.
27. Tavernier, G., Toumaniantz, G., Erfanian, M., Heymann, M.F., Laurent, K., Langin, D., and Gauthier, C. 2003. β3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human β3-adrenergic receptor. Cardiovasc. Res. 59: 288-296. doi:10.1016/S0008-6363(03)00359-6.